iRhythm Holdings stock declined 2.7% in a month despite strong results, pressured by sector rotation and a DOJ inquiry.
iRhythm Holdings (NASDAQ:IRTC) closed at $112.47 on June 24, 2026, down 2.7% over the past month despite posting better-than-expected Q1 2026 earnings and raising full-year guidance. The company’s $3.7 billion market cap reflects broader weakness in healthcare equipment stocks as investors shifted to cyclical and tech sectors.
IRTC’s 52-week performance shows a 26.3% decline, underperforming peers. A limited-scope DOJ Civil Investigative Demand related to 2023 mobile cardiac telemetry services added pressure, though the company noted the inquiry accounts for a small portion of sales and risks are already priced in.
The stock’s drop contrasts with its beat-and-raise quarter, highlighting sector-specific headwinds rather than company fundamentals.